Clinical Trial Update: Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating safety, efficacy, tolerability, and pharmacokinetics of LF111 (drospirenone 4.0 mg) for contraception; trial completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• LF111

Snippet

Sponsor: Laboratories Leon Farma, S.A. | Conditions: Contraception | Phase 3 | Status: COMPLETED | Results posted: 2019-07-23